WVE Wave Life Sciences Ltd

Price (delayed)

$3.95

Market cap

$778.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$453.92M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 24

Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Wave's RNA medicines platform, PRISM®, combines multiple modalities, chemistry innovation ...

Highlights
Wave Life Sciences's debt has surged by 177% QoQ and by 101% YoY
The company's net income has shrunk by 56% YoY and by 10% QoQ

Key stats

What are the main financial stats of WVE

WVE stock price

How has the Wave Life Sciences stock price performed over time
Intraday
-9.2%
1 week
-12.32%
1 month
-25.33%
1 year
-42.17%
YTD
-76.76%
QTD
-32.01%

Financial performance

How have Wave Life Sciences's revenue and profit performed over time
Revenue
$65.37M
Gross profit
$65.37M
Operating income
-$217.92M
Net income
-$202.47M
Gross margin
100%
Net margin
-309.7%
Wave Life Sciences's net margin has shrunk by 124% YoY and by 21% QoQ
The operating margin has plunged by 118% YoY and by 22% from the previous quarter
The company's net income has shrunk by 56% YoY and by 10% QoQ
The operating income has plunged by 52% YoY and by 11% from the previous quarter

Price vs fundamentals

How does WVE's price correlate with its fundamentals

Growth

What is Wave Life Sciences's growth rate over time

Valuation

What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
1.68
P/S
12.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.94
Wave Life Sciences's EPS has decreased by 35% YoY and by 2.9% from the previous quarter
The stock's price to book (P/B) is 63% less than its last 4 quarters average of 5.0
The equity has contracted by 11% from the previous quarter
The P/S is 53% below the last 4 quarters average of 29.2 and 45% below the 5-year quarterly average of 24.6
Wave Life Sciences's revenue has decreased by 30% YoY and by 9% QoQ

Efficiency

How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has plunged by 124% YoY and by 21% from the previous quarter
Wave Life Sciences's return on equity has increased by 36% YoY and by 11% QoQ
WVE's return on assets is up by 6% since the previous quarter and by 3.4% year-on-year

Dividends

What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for WVE.

Financial health

How did Wave Life Sciences financials performed over time
The total assets has soared by 121% year-on-year but it is down by 4.3% since the previous quarter
The total liabilities has grown by 46% from the previous quarter
Wave Life Sciences's debt is 90% lower than its equity
Wave Life Sciences's debt has surged by 177% QoQ and by 101% YoY
Wave Life Sciences's debt to equity has decreased by 38% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.